Physician profile
Steve E Rabon
NPI 1053331504
$2,232.17
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,096 · 2020: $30.06 · 2021: $42.84 · 2022: $62.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,135.34 | 2019 | |
| Gemini Mountain Medical, LLC | $942.00 | 2019 | |
| Kci USA, INC. | $44.03 | 2021-2022 | |
| Arthrex, INC. | $30.06 | 2020 | |
| Organogenesis INC. | $28.61 | 2022 | |
| Si-Bone, INC. | $19.52 | 2021 | |
| Merck Sharp & Dohme LLC | $19.01 | 2019 | |
| Nevro Corp. | $13.60 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Rabon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.